about
Metallothionien 3 expression is frequently down-regulated in oesophageal squamous cell carcinoma by DNA methylation.Aspirin and indomethacin for the prevention of experimental port-site metastasesQuantitation of DNA methylation by melt curve analysis.Immune activation in patients with irritable bowel syndrome.Reversal and prevention of arsenic-induced human bronchial epithelial cell malignant transformation by microRNA-200b.Identification of an enhancer that increases miR-200b~200a~429 gene expression in breast cancer cells.The unique transcriptional response produced by concurrent estrogen and progesterone treatment in breast cancer cells results in upregulation of growth factor pathways and switching from a Luminal A to a Basal-like subtypeStromal androgen receptor regulates the composition of the microenvironment to influence prostate cancer outcome.Cerebral arterial fat embolism in the rabbit.Methylation of TIMP3 in esophageal squamous cell carcinomaIGFBP7 is associated with poor prognosis in oesophageal adenocarcinoma and is regulated by promoter DNA methylation.Role of Aquaporin 1 Signalling in Cancer Development and Progression.Fibroblasts derived from oesophageal adenocarcinoma differ in DNA methylation profile from normal oesophageal fibroblasts.Androgen Receptor and Androgen-Responsive Gene FKBP5 Are Independent Prognostic Indicators for Esophageal Adenocarcinoma.A comparison of primary oesophageal squamous epithelial cells with HET-1A in organotypic culture.Methylation of CLDN6, FBN2, RBP1, RBP4, TFPI2, and TMEFF2 in esophageal squamous cell carcinoma.The effects of high-dose esomeprazole on gastric and oesophageal acid exposure and molecular markers in Barrett's oesophagus.The effect of long-term control of reflux by fundoplication on aberrant deoxyribonucleic acid methylation in patients with Barrett esophagus.Fat distribution and changes in the blood brain barrier in a rat model of cerebral arterial fat embolism.The Aquaporin 1 Inhibitor Bacopaside II Reduces Endothelial Cell Migration and Tubulogenesis and Induces Apoptosis.Myofibroblast androgen receptor expression determines cell survival in co-cultures of myofibroblasts and prostate cancer cells in vitro.The Purified Extract from the Medicinal Plant , Bacopaside II, Inhibits Growth of Colon Cancer Cells In Vitro by Inducing Cell Cycle Arrest and ApoptosisGinsenoside Rg3: Potential Molecular Targets and Therapeutic Indication in Metastatic Breast CancerBumetanide-Derived Aquaporin 1 Inhibitors, AqB013 and AqB050 Inhibit Tube Formation of Endothelial Cells through Induction of Apoptosis and Impaired Migration In VitroImmune cell subpopulations in regenerated splenic tissue in ratsDecreased phagocytic capacity of autotransplanted splenic tissueTumor implantation during laparoscopy using different insufflation gases - an experimental study using cultured cancer cellsBacopasides I and II Act in Synergy to Inhibit the Growth, Migration and Invasion of Breast Cancer Cell LinesReduced aquaporin-1 transcript expression in colorectal carcinoma is associated with promoter hypermethylationCombined pharmacological administration of AQP1 ion channel blocker AqB011 and water channel blocker Bacopaside II amplifies inhibition of colon cancer cell migration
P50
Q25256949-CF8756BE-5429-4960-8C2C-79050AC9289CQ28209937-274E0A12-9A06-4C17-A530-0970ED79DC7AQ33434920-A321F651-B1D6-4FEE-93EC-114B9FBA9482Q34612013-9D94AD40-1EEF-4A23-BB95-7289BF5F86DEQ34824379-AF35BDCD-8217-4F06-8A5C-1E764846A936Q35005693-07C1A79E-51C2-4B7F-AFBF-30859268FB30Q35820376-2C46561E-A8B9-4B9E-A72C-058FA959901CQ36140754-9F366912-E099-4F39-996E-95C25597E8D1Q36812350-0E45E60B-42C0-4772-94F6-C00B548356CDQ37174136-EAD233D2-96A4-4068-BEF9-CFACD5A718D4Q37559084-5F457AE6-CF8F-4CB3-A33E-583968295A92Q37690756-0468CE5E-B111-465E-BB80-1A8DC5484E25Q38432514-67F1D45B-9BCE-468C-917B-EAC59427D940Q38827878-B0EACCFF-ED25-4B12-9A1D-30A96A0DB7ADQ39655711-4B3E5078-45F6-4EA8-A3B2-CE78BE1E3D31Q39872514-0FC33C7D-EDB2-4845-895B-959A9E18A002Q42862478-6B382A90-3AB5-41CE-BE56-5B6F7603C3EEQ43940827-5D076353-9CCE-43EC-A26D-FD3AF34FD49EQ48468824-28F028C5-6FFF-492A-AAAB-C671371DCFC6Q51745752-BBCDA3D2-C9CF-4A06-83C0-0432884141B8Q55407443-9674D8D5-58A9-4221-984D-8C259AFE219BQ63474008-B433AE53-6A41-4B0E-AE32-2E6AB5F5C046Q64232160-88CF9528-F944-4CDA-A7A5-30633444E16BQ64254662-A95AAC4E-73F4-40E3-BAB9-AE0EAF65C1ADQ78112967-9CE9CB7C-54C2-48BE-8BE5-FEE2A3180A95Q79293113-BAA676A1-2404-41B0-8971-F2E569C27361Q83927807-3D8C3219-A5F3-46FA-A793-417C5F9AB94CQ90418795-A66FE64D-B154-4029-8EA2-CC387ACAF931Q91439439-C3104986-C5AA-4506-AB12-E9F3295937FBQ93064101-96FE1BD2-F3E4-49AC-971D-3DA1FF8A0E72
P50
description
medical researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Eric Smith
@ast
Eric Smith
@en
Eric Smith
@es
Eric Smith
@nl
Eric Smith
@sl
type
label
Eric Smith
@ast
Eric Smith
@en
Eric Smith
@es
Eric Smith
@nl
Eric Smith
@sl
prefLabel
Eric Smith
@ast
Eric Smith
@en
Eric Smith
@es
Eric Smith
@nl
Eric Smith
@sl
P106
P31
P496
0000-0003-2958-3492